Literature DB >> 1768572

Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese.

N J Osborne1, A L Tonkin, J O Miners.   

Abstract

Paracetamol disposition following a single oral 1 g dose of the drug was compared in groups (n = 12) of healthy young adult male Caucasians and Chinese. There was no difference between the groups in terms of paracetamol oral clearance, elimination half-life, or partial metabolic (glucuronidation, sulphation, oxidation) and renal clearances. The results demonstrate that drug glucuronidation is not universally impaired in Chinese and, together with previously published data, that paracetamol glucuronidation is minimally affected by race.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768572      PMCID: PMC1368561     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

Review 2.  N-acetyltransferase.

Authors:  D A Evans
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 3.  The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

Authors:  M Eichelbaum; A S Gross
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 4.  UDP-glucuronosyltransferases.

Authors:  B Burchell; M W Coughtrie
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 5.  Genetic polymorphism of S-mephenytoin hydroxylation.

Authors:  G R Wilkinson; F P Guengerich; R A Branch
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 6.  Ethanol oxidation: ethnic variations in metabolism and response.

Authors:  D P Agarwal; H W Goedde
Journal:  Prog Clin Biol Res       Date:  1986

7.  Inter-subject and ethnic differences in paracetamol metabolism.

Authors:  J A Critchley; G R Nimmo; C A Gregson; N M Woolhouse; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

8.  Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism.

Authors:  J Sonne; H E Poulsen; S Loft; M Døssing; A Vollmer-Larsen; K Simonsen; H Thyssen; K Lundstrøm
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Race and therapeutic drug response.

Authors:  W Kalow
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

10.  Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

Authors:  Q Y Yue; J O Svensson; C Alm; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

View more
  4 in total

1.  Perturbation of paracetamol urinary metabolic ratios by urine flow rate.

Authors:  J O Miners; N J Osborne; A L Tonkin; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia.

Authors:  Dong-Wook Kim; Eugene Y Tan; Yu Jin; Sahee Park; Michael Hayes; Eren Demirhan; Horst Schran; Yanfeng Wang
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

3.  The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.

Authors:  Michael H Court; Marina Freytsis; Xueding Wang; Inga Peter; Chantal Guillemette; Suwagmani Hazarika; Su X Duan; David J Greenblatt; William M Lee
Journal:  J Pharmacol Exp Ther       Date:  2013-02-13       Impact factor: 4.030

Review 4.  Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Authors:  B Burchell; M W Coughtrie
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.